Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Silverback Therapeutics Inc.
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-03-03
Purchase
2022-03-18
5:14 pm
Silverback Therapeutics Inc. SBTX ROOT JONATHAN D
Director
2,364 $15.25 $36,048 2,271,781
(Indirect
Direct)
View
2020-12-08
Purchase(A)
2022-02-24
7:55 pm
Silverback Therapeutics Inc. SBTX Hawkinson Russ
VP
200 $21 $4,200 200
(Direct)
View
2020-12-08
Purchase
2020-12-08
9:04 pm
Silverback Therapeutics Inc. SBTX Presidio Management Group XII L.L.C.
U.S. Venture Partners XII L.P.
U.S. Venture Partners XII-A L.P.
Tansey Casey M
10% Owner
47,619 $21 $999,999 47,619
(Indirect)
View
2020-12-08
Purchase
2020-12-08
8:56 pm
Silverback Therapeutics Inc. SBTX CAPPS VICKIE L
Director
9,523 $21 $199,983 61,576
(Direct)
View
2020-12-08
Purchase
2020-12-08
8:52 pm
Silverback Therapeutics Inc. SBTX Hawkinson Russ
VP
238 $21 $4,998 238
(Direct)
View
2020-12-08
Purchase
2020-12-08
8:50 pm
Silverback Therapeutics Inc. SBTX Piazza Jonathan
CFO
11,904 $21 $249,984 11,904
(Direct)
View
2020-12-08
Purchase
2020-12-08
8:48 pm
Silverback Therapeutics Inc. SBTX Schroeder Thilo
Director
238,096 $21 $5,000,016 1,910,029
(Indirect)
View
2020-12-08
Purchase
2020-12-08
8:46 pm
Silverback Therapeutics Inc. SBTX ROOT JONATHAN D
Director
95,238 $21 $1,999,998 200,250
(Indirect
Direct)
View
2020-12-08
Purchase
2020-12-08
8:43 pm
Silverback Therapeutics Inc. SBTX Thompson Peter A.
Director
10% Owner
1,190,477 $21 $25,000,017 1,221,700
(Indirect)
View
2020-12-08
Purchase
2020-12-08
8:41 pm
Silverback Therapeutics Inc. SBTX ORBIMED ADVISORS LLC
OrbiMed Capital GP VI LLC
ORBIMED CAPITAL LLC
Director
10% Owner
1,190,477 $21 $25,000,017 1,221,700
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-06-10
Option Award
2022-06-13
7:52 pm
N/A
2032-06-09
Silverback Therapeutics Inc. SBTX Thompson Peter A.
Director
10% Owner
18,000 $0 18,000
(Direct)
View
2022-06-10
Option Award
2022-06-13
7:48 pm
N/A
2032-06-09
Silverback Therapeutics Inc. SBTX ROOT JONATHAN D
Director
18,000 $0 18,000
(Direct)
View
2022-06-10
Option Award
2022-06-13
7:44 pm
N/A
2032-06-09
Silverback Therapeutics Inc. SBTX Powell Andrew Kenneth William
Director
18,000 $0 18,000
(Direct)
View
2022-06-10
Option Award
2022-06-13
7:39 pm
N/A
2032-06-09
Silverback Therapeutics Inc. SBTX Koehler Maria
Director
18,000 $0 18,000
(Direct)
View
2022-06-10
Option Award
2022-06-13
7:33 pm
N/A
2032-06-09
Silverback Therapeutics Inc. SBTX Islam Saqib
Director
18,000 $0 18,000
(Direct)
View
2022-06-10
Option Award
2022-06-13
7:31 pm
N/A
2032-06-09
Silverback Therapeutics Inc. SBTX HERSHBERG ROBERT
Director
18,000 $0 18,000
(Direct)
View
2022-06-10
Option Award
2022-06-13
7:27 pm
N/A
2032-06-09
Silverback Therapeutics Inc. SBTX CAPPS VICKIE L
Director
18,000 $0 18,000
(Direct)
View
2022-05-02
Option Award
2022-05-04
5:19 pm
N/A
2032-05-01
Silverback Therapeutics Inc. SBTX Shawver Laura
CEO
204,321 $0 311,716
(Direct)
View
2022-05-02
Option Award
2022-05-04
5:16 pm
N/A
2032-05-01
Silverback Therapeutics Inc. SBTX Piazza Jonathan
CFO
131,074 $0 156,608
(Direct)
View
2022-05-02
Option Award
2022-05-04
5:12 pm
N/A
2032-05-01
Silverback Therapeutics Inc. SBTX Odegard Valerie
President and CSO
135,700 $0 152,106
(Direct)
View
2022-05-02
Option Award
2022-05-04
5:07 pm
N/A
2032-05-01
Silverback Therapeutics Inc. SBTX Hunder Naomi
Chief Medical Officer
129,532 $0 140,782
(Direct)
View
2022-05-02
Option Award
2022-05-04
5:00 pm
N/A
2032-05-01
Silverback Therapeutics Inc. SBTX Hawkinson Russ
VP
85,005 $0 93,921
(Direct)
View
2022-02-01
Option Award
2022-02-02
5:22 pm
N/A
2032-01-31
Silverback Therapeutics Inc. SBTX Hawkinson Russ
VP
81,000 $0 82,454
(Direct)
View
2022-02-01
Option Award
2022-02-02
5:19 pm
N/A
2032-01-31
Silverback Therapeutics Inc. SBTX Piazza Jonathan
CFO
121,500 $0 135,784
(Direct)
View
2022-02-01
Option Award
2022-02-02
5:18 pm
N/A
2032-01-31
Silverback Therapeutics Inc. SBTX Hunder Naomi
Chief Medical Officer
121,500 $0 121,500
(Direct)
View
2022-02-01
Option Award
2022-02-02
5:17 pm
N/A
2032-01-31
Silverback Therapeutics Inc. SBTX Shawver Laura
CEO
297,000 $0 376,895
(Direct)
View
2022-02-01
Option Award
2022-02-02
5:16 pm
N/A
2032-01-31
Silverback Therapeutics Inc. SBTX Odegard Valerie
President and CSO
164,719 $0 164,719
(Direct)
View
2021-12-13
Other
2021-12-15
2:56 pm
N/A
N/A
Silverback Therapeutics Inc. SBTX ROOT JONATHAN D
Director
2,174,179 $0 2,269,417
(Indirect)
View
2021-06-04
Option Award
2021-09-21
5:14 pm
N/A
2031-06-03
Silverback Therapeutics Inc. SBTX Thompson Peter A.
Director
10% Owner
15,000 $0 15,000
(Direct)
View
2021-06-04
Option Award
2021-09-21
5:10 pm
N/A
2031-06-03
Silverback Therapeutics Inc. SBTX ROOT JONATHAN D
Director
15,000 $0 15,000
(Direct)
View
2021-06-04
Option Award
2021-09-21
5:08 pm
N/A
2031-06-03
Silverback Therapeutics Inc. SBTX Powell Andrew Kenneth William
Director
15,000 $0 15,000
(Direct)
View
2021-06-04
Option Award
2021-09-21
5:06 pm
N/A
2031-06-03
Silverback Therapeutics Inc. SBTX Islam Saqib
Director
15,000 $0 15,000
(Direct)
View
2021-06-04
Option Award
2021-09-21
5:04 pm
N/A
2031-06-03
Silverback Therapeutics Inc. SBTX HERSHBERG ROBERT
Director
15,000 $0 15,000
(Direct)
View
2021-06-04
Option Award
2021-09-21
5:03 pm
N/A
2031-06-03
Silverback Therapeutics Inc. SBTX CAPPS VICKIE L
Director
15,000 $0 15,000
(Direct)
View
2021-03-12
Option Award
2021-03-16
3:09 pm
N/A
2031-03-11
Silverback Therapeutics Inc. SBTX Koehler Maria
Director
25,000 $0 25,000
(Direct)
View
2020-12-08
Conversion
2020-12-08
9:04 pm
N/A
N/A
Silverback Therapeutics Inc. SBTX Presidio Management Group XII L.L.C.
U.S. Venture Partners XII L.P.
U.S. Venture Partners XII-A L.P.
Tansey Casey M
10% Owner
10,246,912 $0 47,619
(Indirect)
View
2020-12-08
Conversion
2020-12-08
8:48 pm
N/A
N/A
Silverback Therapeutics Inc. SBTX Schroeder Thilo
Director
7,879,822 $0 1,910,029
(Indirect)
View
2020-12-08
Conversion
2020-12-08
8:46 pm
N/A
N/A
Silverback Therapeutics Inc. SBTX ROOT JONATHAN D
Director
10,246,912 $0 200,250
(Indirect)
View
2020-12-08
Conversion
2020-12-08
8:43 pm
N/A
N/A
Silverback Therapeutics Inc. SBTX Thompson Peter A.
Director
10% Owner
33,046,445 $0 1,221,700
(Indirect)
View
2020-12-08
Conversion
2020-12-08
8:41 pm
N/A
N/A
Silverback Therapeutics Inc. SBTX ORBIMED ADVISORS LLC
OrbiMed Capital GP VI LLC
ORBIMED CAPITAL LLC
Director
10% Owner
33,046,445 $0 1,221,700
(Indirect)
View
2020-12-08
Conversion
2020-12-08
4:36 pm
N/A
N/A
Silverback Therapeutics Inc. SBTX Alexandria Venture Investments LLC
10% Owner
3,296,329 $0 699,412
(Direct)
View
2020-12-03
Option Award
2020-12-07
8:02 pm
N/A
2030-12-02
Silverback Therapeutics Inc. SBTX Thompson Peter A.
Director
10% Owner
38,270 $0 38,270
(Direct)
View
2020-12-03
Option Award
2020-12-07
8:01 pm
N/A
2030-12-02
Silverback Therapeutics Inc. SBTX Odegard Valerie
President and CSO
364,904 $0 364,904
(Direct)
View
2020-12-03
Option Award
2020-12-07
7:59 pm
N/A
2030-12-02
Silverback Therapeutics Inc. SBTX Shawver Laura
CEO
562,631 $0 562,631
(Direct)
View
(A) Indicate amendment filing.
Goto 0, 1, Next